Your browser doesn't support javascript.
loading
[Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients' treatment].
Khripun, A I; Starshinin, A V; Antipova, Y O; Lysenko, M A; Urozhaeva, Y V; Gavrilenko, O F; Rusantsova, N A; Tyazhelnikov, A A; Tikhonovskaya, E Y; Okolot, N V; Sokolova, M V; Fomina, D S; Simonova, E N; Kruglova, T S; Chernov, A A; Zagrebneva, A I.
Affiliation
  • Khripun AI; Department of Health.
  • Starshinin AV; Department of Health.
  • Antipova YO; Department of Health.
  • Lysenko MA; City Clinical Hospital №52.
  • Urozhaeva YV; Pirogov Russian National Research Medical University.
  • Gavrilenko OF; Main Control Department.
  • Rusantsova NA; Medical Inspection Center.
  • Tyazhelnikov AA; Medical Inspection Center.
  • Tikhonovskaya EY; Department of Health.
  • Okolot NV; Consultative and Diagnostic Polyclinic №121.
  • Sokolova MV; City Polyclinic №36.
  • Fomina DS; City Polyclinic №166.
  • Simonova EN; City Polyclinic №191.
  • Kruglova TS; City Clinical Hospital №52.
  • Chernov AA; Sechenov First Moscow State Medical University (Sechenov University).
  • Zagrebneva AI; City Clinical Hospital №52.
Ter Arkh ; 94(5): 668-674, 2022 Jun 17.
Article in Ru | MEDLINE | ID: mdl-36286967
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / COVID-19 Drug Treatment Type of study: Clinical_trials / Observational_studies Limits: Humans Language: Ru Journal: Ter Arkh Year: 2022 Document type: Article Country of publication: RUSSIA
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / COVID-19 Drug Treatment Type of study: Clinical_trials / Observational_studies Limits: Humans Language: Ru Journal: Ter Arkh Year: 2022 Document type: Article Country of publication: RUSSIA